Cargando…

Molecular characterization of Cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from Brazil

BACKGROUND: Cryptosporidium spp. are pathogenic protozoans that play an important role in developing diseases in the elderly, children, and immunosuppressed individuals. METHODS: The objective of this study was to detect and genetically characterize Cryptosporidium spp. in kidney transplanted patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunha, Flávia de Souza, Jann, Higor Wilson, Lugon, Jocemir Ronaldo, Peralta, José Mauro, Peralta, Regina Helena Saramago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Medicina Tropical - SBMT 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009872/
https://www.ncbi.nlm.nih.gov/pubmed/35416875
http://dx.doi.org/10.1590/0037-8682-0555-2021
_version_ 1784687356727525376
author Cunha, Flávia de Souza
Jann, Higor Wilson
Lugon, Jocemir Ronaldo
Peralta, José Mauro
Peralta, Regina Helena Saramago
author_facet Cunha, Flávia de Souza
Jann, Higor Wilson
Lugon, Jocemir Ronaldo
Peralta, José Mauro
Peralta, Regina Helena Saramago
author_sort Cunha, Flávia de Souza
collection PubMed
description BACKGROUND: Cryptosporidium spp. are pathogenic protozoans that play an important role in developing diseases in the elderly, children, and immunosuppressed individuals. METHODS: The objective of this study was to detect and genetically characterize Cryptosporidium spp. in kidney transplanted patients (n = 97 samples; group 1) and immunosuppressed individuals from an outpatient clinic suspected of having Cryptosporidium infection (n = 53 samples; group 2). All fecal samples were analyzed by parasitological stool examination, immunochromatographic test, and real-time polymerase chain reaction (real-time PCR). Cryptosporidium-positive samples were tested using nested PCR for the gp60 gene, followed by sequencing for subtype determination. RESULTS: Parasitological examination was negative in all Group 1, and positive in four Group 2 samples. Real-time PCR revealed Cryptosporidium in 13 samples: four in Group 1 (three C. hominis and one C. parvum) and nine in Group 2 (seven C. hominis, one C. parvum, and one mixed C. hominis/C. parvum). The immunochromatographic test was reactive in 11 samples (four in Group 1 and seven in Group 2). All 11 C. hominis isolates were identified as subtype IbA10G2 and one C. parvum as subtype IIbA15G2R1. All C. hominis belonged to subtype IbA10G2, which is recognized as the most prevalent and pathogenic subtype. CONCLUSIONS: This study showed, for the first time, that the presence of Cryptosporidium subtypes is considered more virulent in Brazilian transplanted kidney patients.
format Online
Article
Text
id pubmed-9009872
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedade Brasileira de Medicina Tropical - SBMT
record_format MEDLINE/PubMed
spelling pubmed-90098722022-04-26 Molecular characterization of Cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from Brazil Cunha, Flávia de Souza Jann, Higor Wilson Lugon, Jocemir Ronaldo Peralta, José Mauro Peralta, Regina Helena Saramago Rev Soc Bras Med Trop Major Article BACKGROUND: Cryptosporidium spp. are pathogenic protozoans that play an important role in developing diseases in the elderly, children, and immunosuppressed individuals. METHODS: The objective of this study was to detect and genetically characterize Cryptosporidium spp. in kidney transplanted patients (n = 97 samples; group 1) and immunosuppressed individuals from an outpatient clinic suspected of having Cryptosporidium infection (n = 53 samples; group 2). All fecal samples were analyzed by parasitological stool examination, immunochromatographic test, and real-time polymerase chain reaction (real-time PCR). Cryptosporidium-positive samples were tested using nested PCR for the gp60 gene, followed by sequencing for subtype determination. RESULTS: Parasitological examination was negative in all Group 1, and positive in four Group 2 samples. Real-time PCR revealed Cryptosporidium in 13 samples: four in Group 1 (three C. hominis and one C. parvum) and nine in Group 2 (seven C. hominis, one C. parvum, and one mixed C. hominis/C. parvum). The immunochromatographic test was reactive in 11 samples (four in Group 1 and seven in Group 2). All 11 C. hominis isolates were identified as subtype IbA10G2 and one C. parvum as subtype IIbA15G2R1. All C. hominis belonged to subtype IbA10G2, which is recognized as the most prevalent and pathogenic subtype. CONCLUSIONS: This study showed, for the first time, that the presence of Cryptosporidium subtypes is considered more virulent in Brazilian transplanted kidney patients. Sociedade Brasileira de Medicina Tropical - SBMT 2022-04-08 /pmc/articles/PMC9009872/ /pubmed/35416875 http://dx.doi.org/10.1590/0037-8682-0555-2021 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Major Article
Cunha, Flávia de Souza
Jann, Higor Wilson
Lugon, Jocemir Ronaldo
Peralta, José Mauro
Peralta, Regina Helena Saramago
Molecular characterization of Cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from Brazil
title Molecular characterization of Cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from Brazil
title_full Molecular characterization of Cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from Brazil
title_fullStr Molecular characterization of Cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from Brazil
title_full_unstemmed Molecular characterization of Cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from Brazil
title_short Molecular characterization of Cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from Brazil
title_sort molecular characterization of cryptosporidium spp. obtained from fecal samples of immunosuppressed patients from brazil
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009872/
https://www.ncbi.nlm.nih.gov/pubmed/35416875
http://dx.doi.org/10.1590/0037-8682-0555-2021
work_keys_str_mv AT cunhaflaviadesouza molecularcharacterizationofcryptosporidiumsppobtainedfromfecalsamplesofimmunosuppressedpatientsfrombrazil
AT jannhigorwilson molecularcharacterizationofcryptosporidiumsppobtainedfromfecalsamplesofimmunosuppressedpatientsfrombrazil
AT lugonjocemirronaldo molecularcharacterizationofcryptosporidiumsppobtainedfromfecalsamplesofimmunosuppressedpatientsfrombrazil
AT peraltajosemauro molecularcharacterizationofcryptosporidiumsppobtainedfromfecalsamplesofimmunosuppressedpatientsfrombrazil
AT peraltareginahelenasaramago molecularcharacterizationofcryptosporidiumsppobtainedfromfecalsamplesofimmunosuppressedpatientsfrombrazil